NASDAQ:GNPX

Genprex Stock Insider Trading

etoro logo Buy GNPX
*Your capital is at risk
$0.720
-0.0153 (-2.08%)
At Close: Jun 03, 2026

Genprex Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 70.19. In total, the insiders bought 12.33M and sold 49.2K GNPX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
70.19
Buy 12.33M shares
Sell 49.2K shares
82% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Feb 27, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 70.19.
  • Confidence increased due to high data reliability score of 80.

Historical Insider Trades

Date Type Person Role Amount
Feb 04, 2022
Buy
Stock Option (right to buy)
A-Award
Varner John Rodney
President & CEO
CEO / President 1 062 250
Value: $2.34M
Feb 04, 2022
Buy
Stock Option (right to buy)
A-Award
Kumar Hermant
Chief Mfgr & Tech Officer
Officer 54 312
Value: $119.5K
Feb 04, 2022
Buy
Stock Option (right to buy)
A-Award
Kumar Hermant
Chief Mfgr & Tech Officer
Officer 54 312
Value: $119.5K
Feb 04, 2022
Buy
Stock Option (right to buy)
A-Award
Berger Mark Stanley
Chief Medical Officer
Officer 98 750
Value: $217.3K
Feb 04, 2022
Buy
Stock Option (right to buy)
A-Award
Varner John Rodney
President & CEO
CEO / President 1 062 250
Value: $2.34M
Feb 04, 2022
Buy
Stock Option (right to buy)
A-Award
Vaczy Catherine M
EVP GC Chief Strategy Officer
Officer 325 000
Value: $715.0K
Feb 04, 2022
Buy
Stock Option (right to buy)
A-Award
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 341 750
Value: $751.9K
Feb 04, 2022
Buy
Stock Option (right to buy)
A-Award
Vaczy Catherine M
EVP GC Chief Strategy Officer
Officer 325 000
Value: $715.0K
Dec 31, 2021
Buy
Common Stock
Varner John Rodney
President & CEO
CEO / President 0
Value: $0
Dec 31, 2021
Buy
Common Stock
Varner John Rodney
President & CEO
CEO / President 0
Value: $0
Dec 31, 2021
Buy
Common Stock
Varner John Rodney
President & CEO
CEO / President 0
Value: $0
Dec 31, 2021
Buy
Common Stock
Varner John Rodney
President & CEO
CEO / President 0
Value: $0
Sep 27, 2021
Buy
Stock Option (right to buy)
A-Award
Berger Mark Stanley
Chief Medical Officer
Officer 550 000
Value: $1.57M
Sep 27, 2021
Buy
Common Stock
J-Other
Berger Mark Stanley
Officer
Officer 0
Value: $0
Sep 27, 2021
Buy
Common Stock
J-Other
Kumar Hermant
Officer
Officer 0
Value: $0
Sep 27, 2021
Buy
Common Stock
J-Other
Berger Mark Stanley
Officer
Officer 0
Value: $0
Sep 27, 2021
Buy
Stock Option (right to buy)
A-Award
Kumar Hermant
Chief Mfgr & Tech Officer
Officer 400 000
Value: $1.14M
Sep 27, 2021
Buy
Stock Option (right to buy)
A-Award
Kumar Hermant
Chief Mfgr & Tech Officer
Officer 400 000
Value: $1.14M
Sep 27, 2021
Buy
Stock Option (right to buy)
A-Award
Berger Mark Stanley
Chief Medical Officer
Officer 550 000
Value: $1.57M
Oct 01, 2016
Buy
Stock option (right to buy)
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 86 894
Value: $459.7K
Oct 01, 2016
Buy
Stock option (right to buy)
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 86 894
Value: $459.7K
Apr 11, 2016
Buy
Stock option (right to buy)
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 161 396
Value: $155.7K
Apr 11, 2016
Buy
Stock option (right to buy)
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 161 396
Value: $155.7K
Aug 01, 2013
Buy
Stock option (right to buy)
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 116 973
Value: $2K
Aug 01, 2013
Buy
Stock option (right to buy)
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 116 973
Value: $2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT GENPREX INC.
Genprex
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE